|
||||||
|
 | Fusion Gene Summary |
| Fusion Gene ORF analysis |
| Fusion Genomic Features |
| Fusion Protein Features |
| Fusion Gene Sequence |
| Fusion Gene PPI analysis |
| Related Drugs |
| Related Diseases |
Fusion gene:AKT1S1-CMTM4 (FusionGDB2 ID:3471) |
Fusion Gene Summary for AKT1S1-CMTM4 |
 Fusion gene summary |
| Fusion gene information | Fusion gene name: AKT1S1-CMTM4 | Fusion gene ID: 3471 | Hgene | Tgene | Gene symbol | AKT1S1 | CMTM4 | Gene ID | 84335 | 146223 |
| Gene name | AKT1 substrate 1 | CKLF like MARVEL transmembrane domain containing 4 | |
| Synonyms | Lobe|PRAS40 | CKLFSF4 | |
| Cytomap | 19q13.33 | 16q21-q22.1 | |
| Type of gene | protein-coding | protein-coding | |
| Description | proline-rich AKT1 substrate 140 kDa proline-rich AKT substrateAKT1 substrate 1 (proline rich) | CKLF-like MARVEL transmembrane domain-containing protein 4chemokine-like factor super family 4chemokine-like factor superfamily member 4 | |
| Modification date | 20200313 | 20200329 | |
| UniProtAcc | Q96B36 | Q8IZR5 | |
| Ensembl transtripts involved in fusion gene | ENST00000344175, ENST00000391831, ENST00000391832, ENST00000391833, ENST00000391834, ENST00000391835, ENST00000482622, | ENST00000330687, ENST00000394106, ENST00000563952, | |
| Fusion gene scores | * DoF score | 2 X 22 X 8=352 | 5 X 4 X 3=60 |
| # samples | 26 | 5 | |
| ** MAII score | log2(26/352*10)=-0.437063805608843 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | log2(5/60*10)=-0.263034405833794 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | |
| Context | PubMed: AKT1S1 [Title/Abstract] AND CMTM4 [Title/Abstract] AND fusion [Title/Abstract] | ||
| Most frequent breakpoint | AKT1S1(50377047)-CMTM4(66647643), # samples:1 | ||
| Anticipated loss of major functional domain due to fusion event. | |||
| * DoF score (Degree of Frequency) = # partners X # break points X # cancer types ** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10) |
| Gene ontology of each fusion partner gene with evidence of Inferred from Direct Assay (IDA) from Entrez |
| Partner | Gene | GO ID | GO term | PubMed ID |
| Hgene | AKT1S1 | GO:0006469 | negative regulation of protein kinase activity | 17386266 |
| Hgene | AKT1S1 | GO:0032007 | negative regulation of TOR signaling | 17386266 |
| Hgene | AKT1S1 | GO:0045792 | negative regulation of cell size | 17386266 |
| Fusion gene breakpoints across AKT1S1 (5'-gene) * Click on the image to open the UCSC genome browser with custom track showing this image in a new window. |
| Fusion gene breakpoints across CMTM4 (3'-gene) * Click on the image to open the UCSC genome browser with custom track showing this image in a new window. |
| Fusion gene information from two resources (ChiTars 5.0 and ChimerDB 4.0) * All genome coordinats were lifted-over on hg19. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
| Source | Disease | Sample | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
| ChiTaRS5.0 | N/A | BM144908 | AKT1S1 | chr19 | 50377047 | - | CMTM4 | chr16 | 66647643 | - |
Top |
Fusion Gene ORF analysis for AKT1S1-CMTM4 |
| Open reading frame (ORF) analsis of fusion genes based on Ensembl gene isoform structure. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
| ORF | Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
| intron-intron | ENST00000344175 | ENST00000330687 | AKT1S1 | chr19 | 50377047 | - | CMTM4 | chr16 | 66647643 | - |
| intron-intron | ENST00000344175 | ENST00000394106 | AKT1S1 | chr19 | 50377047 | - | CMTM4 | chr16 | 66647643 | - |
| intron-intron | ENST00000344175 | ENST00000563952 | AKT1S1 | chr19 | 50377047 | - | CMTM4 | chr16 | 66647643 | - |
| intron-intron | ENST00000391831 | ENST00000330687 | AKT1S1 | chr19 | 50377047 | - | CMTM4 | chr16 | 66647643 | - |
| intron-intron | ENST00000391831 | ENST00000394106 | AKT1S1 | chr19 | 50377047 | - | CMTM4 | chr16 | 66647643 | - |
| intron-intron | ENST00000391831 | ENST00000563952 | AKT1S1 | chr19 | 50377047 | - | CMTM4 | chr16 | 66647643 | - |
| intron-intron | ENST00000391832 | ENST00000330687 | AKT1S1 | chr19 | 50377047 | - | CMTM4 | chr16 | 66647643 | - |
| intron-intron | ENST00000391832 | ENST00000394106 | AKT1S1 | chr19 | 50377047 | - | CMTM4 | chr16 | 66647643 | - |
| intron-intron | ENST00000391832 | ENST00000563952 | AKT1S1 | chr19 | 50377047 | - | CMTM4 | chr16 | 66647643 | - |
| intron-intron | ENST00000391833 | ENST00000330687 | AKT1S1 | chr19 | 50377047 | - | CMTM4 | chr16 | 66647643 | - |
| intron-intron | ENST00000391833 | ENST00000394106 | AKT1S1 | chr19 | 50377047 | - | CMTM4 | chr16 | 66647643 | - |
| intron-intron | ENST00000391833 | ENST00000563952 | AKT1S1 | chr19 | 50377047 | - | CMTM4 | chr16 | 66647643 | - |
| intron-intron | ENST00000391834 | ENST00000330687 | AKT1S1 | chr19 | 50377047 | - | CMTM4 | chr16 | 66647643 | - |
| intron-intron | ENST00000391834 | ENST00000394106 | AKT1S1 | chr19 | 50377047 | - | CMTM4 | chr16 | 66647643 | - |
| intron-intron | ENST00000391834 | ENST00000563952 | AKT1S1 | chr19 | 50377047 | - | CMTM4 | chr16 | 66647643 | - |
| intron-intron | ENST00000391835 | ENST00000330687 | AKT1S1 | chr19 | 50377047 | - | CMTM4 | chr16 | 66647643 | - |
| intron-intron | ENST00000391835 | ENST00000394106 | AKT1S1 | chr19 | 50377047 | - | CMTM4 | chr16 | 66647643 | - |
| intron-intron | ENST00000391835 | ENST00000563952 | AKT1S1 | chr19 | 50377047 | - | CMTM4 | chr16 | 66647643 | - |
| intron-intron | ENST00000482622 | ENST00000330687 | AKT1S1 | chr19 | 50377047 | - | CMTM4 | chr16 | 66647643 | - |
| intron-intron | ENST00000482622 | ENST00000394106 | AKT1S1 | chr19 | 50377047 | - | CMTM4 | chr16 | 66647643 | - |
| intron-intron | ENST00000482622 | ENST00000563952 | AKT1S1 | chr19 | 50377047 | - | CMTM4 | chr16 | 66647643 | - |
| ORFfinder result based on the fusion transcript sequence of in-frame fusion genes. |
| Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | Seq length (transcript) | BP loci (transcript) | Predicted start (transcript) | Predicted stop (transcript) | Seq length (amino acids) |
| DeepORF prediction of the coding potential based on the fusion transcript sequence of in-frame fusion genes. DeepORF is a coding potential classifier based on convolutional neural network by comparing the real Ribo-seq data. If the no-coding score < 0.5 and coding score > 0.5, then the in-frame fusion transcript is predicted as being likely translated. |
| Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | No-coding score | Coding score |
Top |
Fusion Genomic Features for AKT1S1-CMTM4 |
| FusionAI prediction of the potential fusion gene breakpoint based on the pre-mature RNA sequence context (+/- 5kb of individual partner genes, total 20kb length sequence). FusionAI is a fusion gene breakpoint classifier based on convolutional neural network by comparing the fusion positive and negative sequence context of ~ 20K fusion gene data. From here, we can have the relative potentency of the 20K genomic sequence how individual sequnce will be likely used as the gene fusion breakpoints. |
| Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | 1-p | p (fusion gene breakpoint) |
| Distribution of 44 human genomic features loci across 20kb length fusion breakpoint regions. We integrated a total of 44 different types of human genomic feature loci information across five big categories including virus integration sites, repeats, structural variants, chromatin states, and gene expression regulation. More details are in help page. |
| Distribution of 44 human genomic features loci across 20kb length fusion breakpoint regions that are ovelapped with the top 1% feature importance score regions. More details are in help page. |
Top |
Fusion Protein Features for AKT1S1-CMTM4 |
| Four levels of functional features of fusion genes Go to FGviewer search page for the most frequent breakpoint (https://ccsmweb.uth.edu/FGviewer/:50377047/:66647643) - FGviewer provides the online visualization of the retention search of the protein functional features across DNA, RNA, protein, and pathological levels. - How to search 1. Put your fusion gene symbol. 2. Press the tab key until there will be shown the breakpoint information filled. 4. Go down and press 'Search' tab twice. 4. Go down to have the hyperlink of the search result. 5. Click the hyperlink. 6. See the FGviewer result for your fusion gene. |
 |
| Main function of each fusion partner protein. (from UniProt) |
| Hgene | Tgene |
| AKT1S1 | CMTM4 |
| FUNCTION: Subunit of mTORC1, which regulates cell growth and survival in response to nutrient and hormonal signals. mTORC1 is activated in response to growth factors or amino acids. Growth factor-stimulated mTORC1 activation involves a AKT1-mediated phosphorylation of TSC1-TSC2, which leads to the activation of the RHEB GTPase that potently activates the protein kinase activity of mTORC1. Amino acid-signaling to mTORC1 requires its relocalization to the lysosomes mediated by the Ragulator complex and the Rag GTPases. Activated mTORC1 up-regulates protein synthesis by phosphorylating key regulators of mRNA translation and ribosome synthesis. mTORC1 phosphorylates EIF4EBP1 and releases it from inhibiting the elongation initiation factor 4E (eiF4E). mTORC1 phosphorylates and activates S6K1 at 'Thr-389', which then promotes protein synthesis by phosphorylating PDCD4 and targeting it for degradation. Within mTORC1, AKT1S1 negatively regulates mTOR activity in a manner that is dependent on its phosphorylation state and binding to 14-3-3 proteins. Inhibits RHEB-GTP-dependent mTORC1 activation. Substrate for AKT1 phosphorylation, but can also be activated by AKT1-independent mechanisms. May also play a role in nerve growth factor-mediated neuroprotection. {ECO:0000269|PubMed:16174443, ECO:0000269|PubMed:17277771, ECO:0000269|PubMed:17386266}. | FUNCTION: Acts as a backup for CMTM6 to regulate plasma membrane expression of PD-L1/CD274, an immune inhibitory ligand critical for immune tolerance to self and antitumor immunity. May protect PD-L1/CD274 from being polyubiquitinated and targeted for degradation. {ECO:0000269|PubMed:28813410}. |
| Retention analysis result of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features. Here, because of limited space for viewing, we only show the protein feature retention information belong to the 13 regional features. All retention annotation result can be downloaded at * Minus value of BPloci means that the break pointn is located before the CDS. |
| - In-frame and retained protein feature among the 13 regional features. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
| - In-frame and not-retained protein feature among the 13 regional features. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Top |
Fusion Gene Sequence for AKT1S1-CMTM4 |
| For in-frame fusion transcripts, we provide the fusion transcript sequences and fusion amino acid sequences. To have fusion amino acid sequence, we ran ORFfinder and chose the longest ORF among the all predicted ones. |
Top |
Fusion Gene PPI Analysis for AKT1S1-CMTM4 |
| Go to ChiPPI (Chimeric Protein-Protein interactions) to see the chimeric PPI interaction in |
| Protein-protein interactors with each fusion partner protein in wild-type (BIOGRID-3.4.160) |
| Hgene | Hgene's interactors | Tgene | Tgene's interactors |
| - Retained PPIs in in-frame fusion. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Still interaction with |
| - Lost PPIs in in-frame fusion. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
| - Retained PPIs, but lost function due to frame-shift fusion. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
Top |
Related Drugs for AKT1S1-CMTM4 |
| Drugs targeting genes involved in this fusion gene. (DrugBank Version 5.1.8 2021-05-08) |
| Partner | Gene | UniProtAcc | DrugBank ID | Drug name | Drug activity | Drug type | Drug status |
Top |
Related Diseases for AKT1S1-CMTM4 |
| Diseases associated with fusion partners. (DisGeNet 4.0) |
| Partner | Gene | Disease ID | Disease name | # pubmeds | Source |
Copyright 2021-Present -The University of Texas Health Science Center at Houston (UTHealth)
Web File Viewing | Emergency Information |Campus Carry|Site Policies